LY2118

Model Information:

Gastric cancer, tumor mass: 8cm x 7cm, inflammatory cells infiltrated through body and gastric antrum, Small tumor foci are remained, consistent with the changes after chemotherapy. Regional LN: right cardial LN (0/5), left cardial LN (0/7), LN of vasa brevia (0/2), left gastroepiploic vascular LN (0/2), right gastroepiploic vascular LN (0/1), inferior pyloric LN (0/1), LN of left gastric artery (0/3), LN of hepatic artery in ligamentum hepatoduodenale(0/1). IHC results: CD44(+), Cmet(weak +), EGFR(+), HER2(3+), Ki-67(+50-75%), MMP7(-), P170(-), P27(+50-75%), P53(+>75%), TOPOII(-).

Summary 
Cancer Typelymphoma
SubtypeEBV transformed lymphoma
GradeIIB
StageT4N2M0,IIIb
EthnicityAsian
GenderM
Age72
Pathology DiagnosisGastric cancer, tumor mass: 8cm x 7cm, inflammatory cells infiltrated through body and gastric antrum, Small tumor foci are remained, consistent with the changes after chemotherapy. Regional LN: right cardial LN (0/5), left cardial LN (0/7), LN of vasa brevia (0/2), left gastroepiploic vascular LN (0/2), right gastroepiploic vascular LN (0/1), inferior pyloric LN (0/1), LN of left gastric artery (0/3), LN of hepatic artery in ligamentum hepatoduodenale(0/1). IHC results: CD44(+), Cmet(weak +), EGFR(+), HER2(3+), Ki-67(+50-75%), MMP7(-), P170(-), P27(+50-75%), P53(+>75%), TOPOII(-).
Biopsy SiteNA
Treatment HistoryNA
Pathology QCEBV+ lymphoma; Large cell poorly differentiated malignant tumor, accord with anaplastic large cell lymphoma (P3)
Special FeaturesSlight BW loss; revival take rate is low
Mouse StrainNOD SCID
TMANA
Viral Status in PDXEBV+ (P3, RNAseq)
Available InCB_CN
RNA SeqP3
Exome SeqP3

Growth Characteristics

Additional Characteristics

Create HuBase Account to View All Model Data

Already Registered? Login